Morgan Stanley Maintains Equal-Weight on West Pharmaceutical Servs, Raises Price Target to $365

Benzinga Newsdesk www.benzinga.com Positive 51.7%

Neg 0% Neu 0% Pos 51.7%

Morgan Stanley analyst Kallum Titchmarsh maintains West Pharmaceutical Servs (NYSE:WST) with a Equal-Weight and raises the price target from $325 to $365.